Stantec Q3 Beats: Record 20.2% EBITDA Margin, 2026 Guidance Raised
STN is trading near its 52-week low of $65.35 (15% above the low).
Summary
Stantec reported strong Q3 2026 results with 9.4% net revenue growth, a record 20.2% adjusted EBITDA margin, and raised its 2026 profitability guidance.
Key Events · Earnings and Guidance · STN
-
Q3 Revenue Grows 9.4%
Net revenue rose 9.4% to C$1.9 billion, driven by 5.3% organic growth and 2.6% acquisition growth.
-
Record 20.2% EBITDA Margin
Adjusted EBITDA increased 16.6% to C$377.1 million, with margin up 120 basis points to a record 20.2%.
-
2026 Guidance Raised
Adjusted EBITDA margin target lifted to 18.3%-18.5% and adjusted EPS growth to 17%-19%, from 15%-18% previously.
-
Backlog at C$9.2 Billion
Contract backlog rose 11.6% year-over-year, including 9.9% organic growth, representing about 13 months of work.
Analysis · STN · Trade & Services
Stantec delivered 9.4% net revenue growth to C$1.9 billion and a record 20.2% adjusted EBITDA margin, up 120 basis points, with adjusted EPS up 23.5% to C$1.89. Management raised full-year profitability targets — adjusted EBITDA margin to 18.3%-18.5% and adjusted EPS growth to 17%-19% — on strong project margins and cost discipline. Backlog of C$9.2 billion, about 13 months of work, supports the outlook into 2027.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STN was trading at $75.13 on NYSE in the Trade & Services sector, with a market capitalization of approximately $8.4B. The 52-week trading range was $65.35 to $108.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.